Evonik plans to invest $100 million over five years to modernise its Lafayette, Indiana drug substance contract manufacturing site.
The upgrade covers 100 m³ reactors and critical systems to lift reliability, automation, ergonomics and efficiency.
The company says the project supports rising US-based CDMO demand and complex API manufacturing.
Source link
Germany's Evonik invests $100 mn in Indiana API plant
By Saartaj
Related Posts
US container imports steady in June despite trade tensions: Report
US containerised imports remained resilient in June 2026, easing 1.2 per cent from May to 2.40 million TEUs…
BySaartajM&S debuts shoppable collection at London Fashion Week
Category Select Category Apparel/Garments Textiles Fashion Technical Textiles Information Technology E-commerce Retail Corporate Association Press Release Chemicals SubCategory Select Sub-Category Country Select Country Afghanistan Africa Albania Algeria Andorra Angola Argentina Armenia Aruba Asia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin bhutan Bolivia Bosnia…
BySaartajFrance's TotalEnergies ships first ECA LNG cargo to Asia
TotalEnergies has shipped the first ECA LNG Phase 1 cargo from Mexico’s Pacific Coast to Asia as the…
BySaartajDubai to host FESPA Middle East 2027 from April 27–29
FESPA Middle East has announced that its 2027 edition will take place from 27–29 April 2027 at the…
BySaartajTrending Posts
Gallery